AI assistant
Amphastar Pharmaceuticals, Inc. — Director's Dealing 2014
Jun 25, 2014
10216_dirs_2014-06-24_68f29711-c32e-45cc-ba44-fdfdcff13734.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: Amphastar Pharmaceuticals, Inc. (AMPH)
CIK: 0001297184
Period of Report: 2014-06-24
Reporting Person: Gerst Diane G. (Corp. Sr. VP of Quality Assur.)
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 4728 | Direct |
| Common Stock | 8080 | Direct |
Holdings (Derivative)
| Security | Exercise Price | Expiration | Underlying | Shares | Ownership |
|---|---|---|---|---|---|
| Stock Option (Right to Buy) | $14.8 | 2014-07-28 | Common Stock (10000) | Direct | |
| Stock Option (Right to Buy) | $14.8 | 2015-05-15 | Common Stock (9782) | Direct | |
| Stock Option (Right to Buy) | $14.8 | 2015-05-15 | Common Stock (218) | Direct | |
| Stock Option (Right to Buy) | $30.57 | 2016-12-21 | Common Stock (4000) | Direct | |
| Stock Option (Right to Buy) | $30.57 | 2016-12-21 | Common Stock (1000) | Direct | |
| Stock Option (Right to Buy) | $31.65 | 2017-12-30 | Common Stock (8767) | Direct | |
| Stock Option (Right to Buy) | $31.65 | 2017-12-30 | Common Stock (5233) | Direct | |
| Stock Option (Right to Buy) | $35.32 | 2018-08-28 | Common Stock (2522) | Direct | |
| Stock Option (Right to Buy) | $35.32 | 2018-08-28 | Common Stock (8478) | Direct | |
| Stock Option (Right to Buy) | $20.26 | 2019-08-05 | Common Stock (3500) | Direct | |
| Stock Option (Right to Buy) | $20.26 | 2019-08-05 | Common Stock (8500) | Direct | |
| Stock Option (Right to Buy) | $11.41 | 2021-03-08 | Common Stock (9000) | Direct | |
| Stock Option (Right to Buy) | $11.41 | 2021-03-08 | Common Stock (6000) | Direct | |
| Stock Option (Right to Buy) | $14.23 | 2021-12-22 | Common Stock (4954) | Direct | |
| Stock Option (Right to Buy) | $14.23 | 2021-12-22 | Common Stock (10046) | Direct | |
| Stock Option (Right to Buy) | $10.48 | 2022-11-07 | Common Stock (6183) | Direct | |
| Stock Option (Right to Buy) | $10.48 | 2022-11-07 | Common Stock (13817) | Direct | |
| Stock Option (Right to Buy) | $10.93 | 2023-07-30 | Common Stock (8223) | Direct | |
| Stock Option (Right to Buy) | $10.93 | 2023-07-30 | Common Stock (19777) | Direct | |
| Stock Option (Right to Buy) | $14.4 | 2024-04-14 | Common Stock (11775) | Direct |
Footnotes
F1: This represents deferred stock units that were granted on 4/14/2014 and vest over 4 years in equal annual installments commencing on the first anniversary of the grant date, subject to the reporting person's continued employment with or service to the Issuer or subsidiary thereof through the applicable vesting date.
F2: This option is fully vested and exercisable.
F3: This option was granted on 8/5/2009 and vests over 5 years in equal annual installments commencing on the first anniversary of the grant date, subject to the reporting person's continued employment with or service to the Issuer or subsidiary thereof through the applicable vesting date.
F4: This option was granted on 8/5/2009 and vests over 5 years in equal annual installments commencing on the first anniversary of the grant date, subject to the reporting person's continued employment with or service to the Issuer or subsidiary thereof through the applicable vesting date.
F5: This option was granted on 3/8/2011 and vests over 5 years in equal annual installments commencing on the first anniversary of the grant date, subject to the reporting person's continued employment with or service to the Issuer or subsidiary thereof through the applicable vesting date.
F6: This option was granted on 3/8/2011 and vests over 5 years in equal annual installments commencing on the first anniversary of the grant date, subject to the reporting person's continued employment with or service to the Issuer or subsidiary thereof through the applicable vesting date.
F7: This option was granted on 12/22/2011 and vests over 4 years in equal annual installments commencing on the first anniversary of the grant date, subject to the reporting person's continued employment with or service to the Issuer or subsidiary thereof through the applicable vesting date.
F8: This option was granted on 12/22/2011 and vests over 4 years in equal annual installments commencing on the first anniversary of the grant date, subject to the reporting person's continued employment with or service to the Issuer or subsidiary thereof through the applicable vesting date.
F9: This option was granted on 11/7/2012 and vests over 4 years in equal annual installments commencing on the first anniversary of the grant date, subject to the reporting person's continued employment with or service to the Issuer or subsidiary thereof through the applicable vesting date.
F10: This option was granted on 11/7/2012 and vests over 4 years in equal annual installments commencing on the first anniversary of the grant date, subject to the reporting person's continued employment with or service to the Issuer or subsidiary thereof through the applicable vesting date.
F11: This option was granted on 7/30/2013 and vests over 4 years in equal annual installments commencing on the first anniversary of the grant date, subject to the reporting person's continued employment with or service to the Issuer or subsidiary thereof through the applicable vesting date.
F12: This option was granted on 7/30/2013 and vests over 4 years in equal annual installments commencing on the first anniversary of the grant date, subject to the reporting person's continued employment with or service to the Issuer or subsidiary thereof through the applicable vesting date.
F13: This option was granted on 4/14/2014 and vests over 4 years in equal annual installments commencing on the first anniversary of the grant date, subject to the reporting person's continued employment with or service to the Issuer or subsidiary thereof through the applicable vesting date.